Investors did not see the clinical trial results they wanted.
News & Analysis: Athenex, Inc.
The remaining weeks of December are chock-full of clinical trial results and FDA approval decisions that savvy investors can take advantage of.
Promising new results in breast cancer will be presented at next week's San Antonio Breast Cancer Symposium. Here's what to look for.
The title of a scientific abstract suggests that additional data from its lead pipeline program will bolster the case for regulatory approval.
ATNX earnings call for the period ending September 30, 2019.
Shares jump after news breaks that a big investor recently added to its position.
ATNX earnings call for the period ending June 30, 2019.
ATNX earnings call for the period ending March 31, 2019.
Despite pressure on the broader market, these stocks bucked the downtrend.
ATNX earnings call for the period ending December 31, 2018.